UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
(Mark One)
[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended FEBRUARY 29, 2004
OR
[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
For the transition period from ___________________ to ______________________
Commission File No. 0-11488
PENFORD CORPORATION
(Exact name of registrant as specified in its charter)
Washington 91-1221360
- ---------------------------------------- ------------------------------------
(State of Incorporation) (I.R.S. Employer
Identification No.)
7094 South Revere Parkway,
Englewood, Colorado 80112-3932
- ---------------------------------------- ------------------------------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (303) 649-1900
Indicate by a check mark whether the registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of
1934 during the preceding 12 months (or for such shorter period that the
registrant was required to file such reports), and (2) has been subject to such
filing requirements for the past 90 days. Yes [X] No [ ]
Indicate by checkmark whether the registrant is an accelerated filer (as defined
in Rule 12b-2 of the Exchange Act Yes [X] No [ ]
The net number of shares of the Registrant's common stock (the Registrant's only
outstanding class of stock) outstanding as of April 8, 2004 was 8,765,373.
PENFORD CORPORATION AND SUBSIDIARIES
INDEX
Page
----
PART I -- FINANCIAL INFORMATION
Item 1. Financial Statements
Condensed Consolidated Balance Sheets - February 29, 2004 and August 31, 2003 3
Condensed Consolidated Statements of Income - Three and Six Months ended
February 29, 2004 and February 28, 2003 4
Condensed Consolidated Statements of Cash Flow - Six Months ended
February 29, 2004 and February 28, 2003 5
Notes to Condensed Consolidated Financial Statements 6
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations 12
Item 3. Quantitative and Qualitative Disclosures About Market Risk 15
Item 4. Controls and Procedures 15
PART II -- OTHER INFORMATION
Item 4. Submission of Matters to a Vote of Security Holders 16
Item 6. Exhibits and Reports on Form 8-K 16
Signatures 17
2
PART I - FINANCIAL INFORMATION
ITEM 1: FINANCIAL STATEMENTS
PENFORD CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
February 29, August 31,
(In thousands, except share and per share data) 2004 2003
- ----------------------------------------------- ------------ ----------
(Unaudited)
ASSETS
Current assets:
Cash $ 6,478 $ 5,697
Trade accounts receivable 38,637 35,809
Inventories 27,040 26,839
Prepaid expenses 3,519 4,168
Other 2,633 3,772
----------- ---------
Total current assets 78,307 76,285
Property, plant and equipment, net 131,860 128,776
Deferred income taxes 9,837 9,853
Restricted cash value of life insurance 12,277 12,136
Goodwill, net 22,123 18,394
Other intangible assets, net 2,650 2,658
Other assets 3,505 2,791
------------ ----------
Total assets $ 260,559 $ 250,893
============ ==========
LIABILITIES AND SHAREHOLDERS' EQUITY
Current liabilities:
Accounts payable $ 18,012 $ 21,853
Accrued pension liability 2,940 2,524
Accrued liabilities 7,556 9,895
Current portion of long-term debt 4,301 3,000
------------ ----------
Total current liabilities 32,809 37,272
Long-term debt 78,112 76,696
Other postretirement benefits 12,127 11,648
Deferred income taxes 19,916 19,914
Other liabilities 17,875 17,478
------------ ----------
Total liabilities 160,839 163,008
Shareholders' equity:
Preferred stock, par value $1.00 per share, authorized 1,000,000 shares,
none issued - -
Common stock, par value $1.00 per share, authorized 29,000,000 shares,
issued 10,743,389 and 10,584,715 shares, respectively 10,743 10,585
Additional paid-in capital 36,325 34,628
Retained earnings 74,818 73,985
Treasury stock, at cost, 1,981,016 shares (32,757) (32,757)
Accumulated other comprehensive income 10,591 1,444
------------ ----------
Total shareholders' equity 99,720 87,885
------------ ----------
Total liabilities and shareholders' equity $ 260,559 $ 250,893
============ ==========
The accompanying notes are an integral part of these statements.
3
PENFORD CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(Unaudited)
Three months ended Six months ended
------------------------ ------------------------
February February February February
(In thousands except share and per share data) 29, 2004 28, 2003 29, 2004 28, 2003
--------------------------------------------- ----------- ----------- ----------- -----------
Sales $ 68,482 $ 61,692 $ 134,652 $ 127,734
Cost of sales 58,574 51,145 114,932 105,302
----------- ----------- ----------- -----------
Gross margin 9,908 10,547 19,720 22,432
Operating expenses 5,483 5,813 11,175 12,180
Research and development expenses 1,454 1,336 2,956 2,748
Restructure costs, net 487 (117) 740 (117)
----------- ----------- ----------- -----------
Income from operations 2,484 3,515 4,849 7,621
Non-operating income, net 530 269 505 2,181
Interest expense 1,185 1,403 2,292 2,984
----------- ----------- ----------- -----------
Income before income taxes 1,829 2,381 3,062 6,818
Income taxes 794 796 1,182 1,935
----------- ----------- ----------- -----------
Net income $ 1,035 $ 1,585 $ 1,880 $ 4,883
=========== =========== =========== ===========
Weighted average common shares and equivalents outstanding:
Basic 8,730,956 7,802,724 8,683,606 7,754,674
Diluted 8,830,901 7,934,858 8,780,022 7,902,764
Earnings per share:
Basic $ 0.12 $ 0.20 $ 0.22 $ 0.63
Diluted $ 0.12 $ 0.20 $ 0.21 $ 0.62
Dividends declared per common share $ 0.06 $ 0.06 $ 0.12 $ 0.12
The accompanying notes are an integral part of these statements.
4
PENFORD CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOW
(Unaudited)
Six Months Ended
--------------------------
(In thousands) February 29, February 28,
2004 2003
------------ ------------
Cash flows from operating activities:
Net income $ 1,880 $ 4,883
Adjustments to reconcile net income to net cash from operations:
Depreciation and amortization 8,927 8,750
Deferred income taxes (222) (951)
Gain on sale of Hi-maize(R) assets - (1,916)
Loss on early extinguishment of debt 665 -
Other 1,001 556
Change in assets and liabilities:
Trade accounts receivable (257) (1,488)
Prepaid expenses 620 115
Inventories 2,685 3,845
Accounts payable and accrued liabilities (6,846) 892
Taxes payable (1,046) 2
Other 1,429 (1,724)
------------ ------------
Net cash provided by operating activities 8,836 12,964
------------ ------------
Cash flows from investing activities:
Investment in property, plant and equipment, net (4,735) (3,260)
Proceeds from sale of Hi-maize(R) assets, net - 2,054
Proceeds from licensing agreement, net - 1,653
Other (159) (267)
------------ ------------
Net cash provided by (used in) investing activities (4,894) 180
------------ ------------
Cash flows from financing activities:
Proceeds from revolving line of credit 35,975 17,747
Payments on revolving line of credit (63,579) (14,299)
Proceeds from long-term debt 50,039 -
Payments of long-term debt (24,134) (12,345)
Exercise of stock options 1,685 819
Payment of loan fees (1,571) (185)
Decrease in cash overdraft - (1,754)
Payment of dividends (1,038) (929)
------------ ------------
Net cash used in financing activities (2,623) (10,946)
------------ ------------
Effect of exchange rate changes on cash and cash equivalents (538) 219
------------ ------------
Net increase in cash and cash equivalents 781 2,417
Cash and cash equivalents, beginning of period 5,697 765
------------ ------------
Cash and cash equivalents end of period $ 6,478 $ 3,182
============ ============
The accompanying notes are an integral part of these statements.
5
PENFORD CORPORATION AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
1-- BUSINESS
Penford Corporation ("Penford" or the "Company") is in the business of
developing, manufacturing and marketing specialty natural-based ingredient
systems for various applications, including papermaking, textiles and food
products. The Company operates manufacturing facilities in the United States,
Australia, and New Zealand. Penford's products provide excellent binding and
film-forming characteristics that make customers' products better through
natural, convenient and cost effective solutions. Sales of the Company's
products are generated using a combination of direct sales and distributor
agreements.
The Company has extensive research and development capabilities, which
are used in understanding the complex chemistry of carbohydrate-based materials
and their application. In addition, the Company has specialty processing
capabilities for a variety of modified starches.
2 -- BASIS OF PRESENTATION
The accompanying condensed consolidated financial statements include
the accounts of Penford and its wholly owned subsidiaries. All material
intercompany transactions and balances have been eliminated. The condensed
consolidated balance sheet at February 29, 2004 and the condensed consolidated
statements of income and cash flows for the interim periods ended February 29,
2004 and February 28, 2003 have been prepared by the Company without audit. In
the opinion of management, all adjustments, consisting only of normal recurring
adjustments, that are necessary to present fairly the financial information have
been made. Certain information and footnote disclosures normally included in
financial statements, prepared in accordance with generally accepted accounting
principles, have been condensed or omitted pursuant to the rules and regulations
of the Securities and Exchange Commission ("SEC"). The results of operations for
interim periods are not necessarily indicative of the operating results of a
full year or of future operations. Certain prior period amounts have been
reclassified to conform with the current period presentation. The accompanying
condensed consolidated financial statements should be read in conjunction with
the consolidated financial statements included in the Company's Annual Report on
Form 10-K for the year ended August 31, 2003.
The Company accounts for its stock-based employee compensation related
to stock options under the intrinsic value recognition and measurement
principles of APB Opinion No. 25, "Accounting for Stock Issued to Employees" and
its various interpretations. Accordingly, no compensation expense has been
recognized for the stock-based compensation plans other than for the Directors'
Plan and restricted stock awards.
The following table illustrates the effect on net income and earnings
per share if the Company had elected to recognize compensation expense
consistent with the provisions prescribed in Statement of Financial Accounting
Standards ("SFAS") No. 123, "Accounting for Stock-Based Compensation," as
amended. Under SFAS No. 123, compensation expense is measured at the grant date
based on the value of the award and is recognized over the vesting period.
6
THREE MONTHS ENDED SIX MONTHS ENDED
------------------ ------------------
FEBRUARY FEBRUARY FEBRUARY FEBRUARY
(In thousands except share and per share data) 29, 2004 28, 2003 29, 2004 28, 2003
--------------------------------------------- -------- -------- -------- --------
Net income, as reported $ 1,035 $ 1,585 $ 1,880 $ 4,883
Add: Stock-based employee compensation expense
included in reported net income, net of tax 19 11 37 43
Less: Stock-based employee compensation expense
determined under the fair value method for
all awards, net of tax (338) (215) (691) (525)
-------- -------- -------- --------
Pro forma net income $ 716 $ 1,381 $ 1,226 4,401
Earnings per share:
Reported basic earnings per common share $ 0.12 $ 0.20 $ 0.22 $ 0.63
======== ======== ======== ========
Reported diluted earnings per common share $ 0.12 $ 0.20 $ 0.21 $ 0.62
======== ======== ======== ========
Pro forma basic earnings per common share $ 0.08 $ 0.18 $ 0.14 $ 0.57
======== ======== ======== ========
Pro forma diluted earnings per common share $ 0.08 $ 0.17 $ 0.14 $ 0.56
======== ======== ======== ========
In December 2003, the Financial Accounting Standards Board ("FASB")
issued revised SFAS No. 132 (revised 2003), "Employer's Disclosure about
Pensions and Other Post-Retirement Benefits." SFAS No. 132 (R) requires
additional disclosures in annual financial statements about the types of plan
assets, investment strategy, measurement dates, plan obligations, cash flows,
and components of net periodic benefit cost of defined benefit pension plans and
other post-retirement benefit plans. The annual disclosure requirements are
effective for fiscal years ending after December 15, 2003. SFAS No. 132 (R) also
requires interim disclosure of the elements of net periodic benefit cost and the
total amount of contributions paid or expected to be paid during the current
fiscal year if significantly different from amounts previously disclosed. The
interim disclosure requirements are effective for interim periods beginning
after December 15, 2003. The Company will adopt the disclosure requirements of
SFAS No. 132 (R) effective with the quarter beginning March 1, 2004.
In January 2004, the FASB issued FASB Staff Position No. 106-1 ("FSP
106-1"), "Accounting and Disclosure Requirements Related to the Medicare
Prescription Drug, Improvement and Modernization Act of 2003" (the "Act"). The
Act introduces a prescription drug benefit under Medicare (Medicare Part D) as
well as a federal subsidy to sponsors of post-retirement health care benefit
plans that provide a benefit that is at least actuarially equivalent to Medicare
Part D. The Company's post-retirement health care benefit plan provides no
prescription drug benefit to Medicare eligible salaried retirees, and the
prescription drug benefit provided to Medicare eligible hourly retirees is
insured and the insurance premium is fully paid by the retirees. The benefits of
the Act are expected to be realized by the Company's retirees and the Act will
have no effect on the Company's results of operations, financial position or
liquidity.
3 -- INVENTORIES
The components of inventory are as follows:
February 29, August 31,
2004 2003
------------ ----------
(In thousands)
Raw materials and other $ 9,184 $ 11,470
Work in progress 688 569
Finished goods 17,168 14,800
------------ ----------
Total inventories $ 27,040 $ 26,839
============ ==========
7
4 -- PROPERTY, PLANT AND EQUIPMENT
February 29, August 31,
2004 2003
------------ ----------
(In thousands)
Land $ 16,326 $ 14,511
Plant and equipment 288,550 278,884
Construction in progress 9,779 7,323
------------ ----------
314,655 300,718
Accumulated depreciation (182,795) (171,942)
------------ ----------
Net property, plant and equipment $ 131,860 $ 128,776
============ ==========
Favorable Australian and New Zealand currency exchange rates have
increased net property, plant and equipment in the first six months of fiscal
2004 by approximately $7.0 million.
5 -- RESTRUCTURING RESERVE
In fiscal 2002, the Company announced a strategic restructuring of its
business operations, including the relocation of its headquarters from
Washington to Colorado. As a result, the Company recorded restructuring costs
totaling $1.4 million related to severance and other exit activity expenses. The
restructuring covered seven employees, all of which were terminated by February
29, 2004. In each of the first and second quarters of fiscal 2004, $0.1 million
in severance costs were paid. The restructuring reserve at February 29, 2004 of
$0.2 million represents remaining severance costs to be paid in fiscal 2004.
In the first quarter of fiscal 2004, the Company's Australian business
implemented an organizational restructure plan and expensed $0.3 million as
restructuring costs related to severance and fringe benefits for five employees.
As of February 29, 2004, all of the employees have been terminated and all
severance and related costs were paid.
In the second quarter of fiscal 2004, the Company's Industrial
Ingredients -- North America business implemented a workforce reduction of 38
employees, all of which have been terminated at February 29, 2004. In connection
therewith, $0.5 million was charged to operating expense as restructuring costs.
The remaining restructure reserve of $0.1 million at February 29, 2004
represents employee benefit costs to be paid by the end of fiscal 2004.
6 -- DEBT
On October 7, 2003, Penford replaced its existing secured credit and
inventory financing credit facilities with a new $105 million secured credit
facility with a group of U.S. and Australian banks. The revolving lines of
credit expire on October 7, 2006 and the term loans expire on October 7, 2008.
Interest rates under the new credit facility are based on either LIBOR (or the
Australian equivalent) or the prime rate, depending on the selection of
borrowing options. All of Penford's assets secure the credit facility and the
new agreement includes, among other things, financial covenants with limitations
on indebtedness and capital expenditures and maintenance of fixed charge and
leverage ratios. For the quarter ended February 29, 2004, the Company was in
compliance with the covenants and expects to be in compliance for the remainder
of the fiscal year. At February 29, 2004, the Company had $32.0 million
outstanding under its revolving credit facilities and $50.4 million in term
loans. The increase in the Company's total debt since August 31, 2003 is
attributable to stronger Australian currency exchange rates.
7 -- TAXES
The Company's effective tax rate for the three and six months ended
February 29, 2004 and February 28, 2003 varied from the U.S. federal statutory
rate due to U. S. tax credits related to research and development and the
favorable tax effect of export sales from the U.S. Income tax expense in the
second quarter of fiscal 2004 included a $0.3 million charge for the effects of
the final implementation of the new Australian consolidation tax legislation.
8
8 -- OTHER COMPREHENSIVE INCOME
The components of total comprehensive income are as follows:
Three months ended Six months ended
------------------ ------------------
February February February February
29, 2004 28, 2003 29, 2004 28, 2003
-------- -------- -------- --------
(In thousands)
Net income $ 1,035 $ 1,585 $ 1,880 $ 4,883
Foreign currency translation adjustments 2,839 3,056 8,405 3,808
Change in unrealized gains on derivative
instruments that qualify as cash flow hedges 718 415 742 63
-------- -------- -------- --------
Total comprehensive income $ 4,592 $ 5,056 $ 11,027 $ 8,754
======== ======== ======== ========
9 -- NON-OPERATING INCOME, NET
Non-operating income, net consists of the following:
Three months ended Six months ended
------------------ ------------------
February February February February
29, 2004 28, 2003 29, 2004 28, 2003
-------- -------- -------- --------
(In thousands)
Loss on early extinguishment of debt $ - $ - $ (665) $ -
Gain on sale of Hi-maize(R) business - - - 1,916
Gain on sale of investment - - 150 -
Royalty and licensing income 396 406 763 406
Other 134 (137) 257 (141)
-------- -------- -------- --------
Total $ 530 $ 269 $ 505 $ 2,181
======== ======== ======== ========
In October 2003, Penford refinanced its existing secured credit and
inventory financing credit agreements and wrote off the unamortized deferred
transaction costs related to these credit agreements. In the first quarter of
fiscal 2003, Penford sold certain assets of its resistant starch Hi-maize(R)
business and recorded a gain on the sale. The Company also licensed the rights
to its resistant starch intellectual property portfolio for applications in
human nutrition. The Company will receive annual royalties for a period of seven
years or until a maximum of $11.0 million has been received. The initial
licensing fee of $2.25 million is being amortized over the life of the royalty
agreement.
9
10 -- SEGMENT REPORTING
Financial information for the Company's three segments is presented
below. The first two segments, Industrial Ingredients -- North America and Food
Ingredients -- North America, are broad categories of end-market users,
primarily served by the Company's U.S. operation. The third segment is the
Company's geographically separate operations in Australia and New Zealand, which
are engaged primarily in the food ingredients business. A fourth item for
"corporate and other" activity is presented to provide reconciliation to amounts
reported in the condensed consolidated financial statements. Corporate and other
represents the activities related to the corporate headquarters such as public
company reporting, personnel costs of the executive management team,
corporate-wide professional services and elimination and consolidation entries.
The elimination of intercompany sales between Australia/New Zealand operations
and Food Ingredients -- North America of $74,000 and $267,000 for the three and
six month periods ended February 29, 2004, respectively, and $277,000 and
$336,000 in the three and six month periods ended February 28, 2003,
respectively, is presented separately since the chief operating decision maker
views segment results prior to intercompany eliminations.
Three months ended Six months ended
------------------- ------------------
February February February February
29, 2004 28, 2003 29, 2004 28, 2003
-------- -------- -------- --------
(In thousands)
Sales:
Industrial Ingredients -- North America $ 35,801 $ 33,672 $ 68,327 $ 69,360
Food Ingredients -- North America 10,973 10,953 22,866 22,463
Australia/New Zealand operations 21,782 17,344 43,726 36,247
Intercompany sales (74) (277) (267) (336)
-------- -------- -------- --------
$ 68,482 $ 61,692 $134,652 $127,734
======== ======== ======== ========
Income from operations:
Industrial Ingredients -- North America (1) $ 1,567 $ 2,396 $ 3,115 $ 5,200
Food Ingredients -- North America 719 1,685 2,618 3,385
Australia/New Zealand operations (2) 1,537 1,017 1,808 2,465
Corporate and other (3) (1,339) (1,583) (2,692) (3,429)
-------- -------- -------- --------
$ 2,484 $ 3,515 $ 4,849 $ 7,621
======== ======== ======== ========
- -----------------
(1) Restructuring costs of $487,000 have been included in income from
operations in the three and six month periods ended February 29, 2004.
(2) Restructuring costs of $253,000 have been included in income from
operations in the six months ended February 29, 2004.
(3) Restructuring reserve adjustment of $(117,000) is included in income from
operations for the three and six months ended February 28, 2003.
February 29, August 31,
2004 2003
----------- ----------
(In thousands)
Total assets:
Industrial Ingredients - North America $ 102,242 $ 106,732
Food Ingredients -- North America 32,699 35,205
Australia/New Zealand operations 97,702 85,269
Corporate and other 27,916 23,687
----------- ----------
$ 260,559 $ 250,893
=========== ==========
10
11 -- EARNINGS PER SHARE
Basic earnings per share reflects only the weighted average common shares
outstanding during the period. Diluted earnings per share reflects weighted
average common shares outstanding and the effect of any dilutive common stock
equivalent shares. The following table presents the computation of diluted
weighted average shares outstanding for the three and six months ended February
29, 2004 and February 28, 2003.
Three months ended Six months ended
-------------------- --------------------
February February February February
29, 2004 28, 2003 29, 2004 28, 2003
--------- --------- --------- ---------
Weighted average common shares outstanding 8,730,956 7,802,724 8,683,606 7,754,674
Dilutive stock options 99,945 132,134 96,416 148,090
Weighted average common shares,
--------- --------- --------- ---------
outstanding, assuming dilution 8,830,901 7,934,858 8,780,022 7,902,764
========= ========= ========= =========
11
ITEM 2: MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND
RESULTS OF OPERATIONS
FORWARD-LOOKING STATEMENTS
The statements contained in this Quarterly Report on Form 10-Q
("Quarterly Report") that are not historical facts, including, but not limited
to statements found in the Notes to Condensed Consolidated Financial Statements
and in Item 2 - Management's Discussion and Analysis of Financial Condition and
Results of Operations, are forward-looking statements that represent
management's beliefs and assumptions based on currently available information.
Forward-looking statements can be identified by the use of words such as
"believes," "may," "will," "looks," "should," "could," "anticipates," "expects,"
or comparable terminology or by discussions of strategies or trends.
Although the Company believes that the expectations reflected in such
forward-looking statements are reasonable, it cannot give any assurances that
these expectations will prove to be correct. Such statements by their nature
involve substantial risks and uncertainties that could significantly affect
expected results. Actual future results could differ materially from those
described in such forward-looking statements, and the Company disclaims any
intention or obligation to update or revise any forward-looking statements,
whether as a result of new information, future events or otherwise. Among the
factors that could cause actual results to differ materially are the risks and
uncertainties discussed in this Quarterly Report, including those referenced
above, and those described from time to time in other filings with the
Securities and Exchange Commission which include, but are not limited to,
competition; the possibility of interruption of business activities due to
equipment problems, accidents, strikes, weather or other factors; product
development risk; changes in corn and other raw material prices and
availability; changes in general economic conditions or developments with
respect to specific industries or customers affecting demand for the Company's
products including unfavorable shifts in product mix; unanticipated costs,
expenses or third party claims; the risk that results may be affected by
construction delays, cost overruns, technical difficulties, nonperformance by
contractors or changes in capital improvement project requirements or
specifications; interest rate and energy cost volatility; foreign currency
exchange rate fluctuations; or other unforeseen developments in the industries
in which Penford operates.
RESULTS OF OPERATIONS
Results of operations for the Company's three segments are presented below.
The first two segments, Industrial Ingredients -- North America and Food
Ingredients -- North America, are broad categories of end-market users,
primarily served by the Company's U.S. operations. The third segment is the
Company's geographically separate operations in Australia and New Zealand, which
are engaged primarily in the food ingredients business. Corporate and other
represents the activities related to the corporate headquarters such as public
company reporting, personnel costs of the executive management team,
corporate-wide professional services and elimination and consolidation entries.
Management Overview
For the three months ended February 29, 2004, consolidated sales
increased $6.8 million or 11% to $68.5 million from $61.7 million in fiscal 2003
driven by stronger Australian and New Zealand currency exchange rates as well as
increased volumes and improved pricing in the Industrial Ingredients -- North
America business segment. The Australian dollar appreciated by 31% compared with
the second quarter of last year. While currency rates have had a favorable
impact on consolidated results of operations, Penford's Australian operations
are being negatively impacted in their ability to export products and compete
with less expensive imports. Sales for the first six months of fiscal 2004 were
$134.7 million, an increase of $6.9 million, or 5%, over the same period in
fiscal 2003. The six-month sales increase is attributable to strong currency
exchange rates offset by volume declines in the Industrial Ingredients and
Australian businesses.
12
Higher natural gas costs in North America and increased manufacturing
costs in the Food Ingredients -- North America business caused consolidated
second quarter 2004 gross margin as a percent of sales to contract to 14.5% from
17.1% last year. The Company's emphasis on controls over discretionary spending
reduced second quarter operating and research and development expenses to 10.1%
of sales from 11.6% of sales in last year's second quarter. Operating income for
the quarter ended February 29, 2004 included $0.5 million of costs related to a
workforce reduction affecting 38 employees in the Industrial Ingredients --
North America business. A discussion of segment results of operations follows.
Sales
Sales at the Company's Industrial Ingredients -- North America business
unit increased by $2.1 million, or 6%, to $35.8 million in the second quarter of
fiscal 2004 compared to the year-ago quarter. Volumes increased by 3%,
accounting for approximately one-half of the increase in sales. The remainder of
the increase is attributable to favorable pricing and an increase in sales of
specialty products. Shipments by Penford's customers remain soft but customer
production curtailments directly impacting Penford's Industrial business have
diminished. Sales for the first half of fiscal 2004 decreased $1.0 million from
last year primarily due to a 3% decrease in sales volumes which was only
partially offset by favorable pricing and product mix.
Sales at Penford's Australia/New Zealand operations rose $4.4 million,
or 26%, and $7.5 million, or 21%, in the three and six month periods ended
February 29, 2004, respectively, compared to the same periods last year. Quarter
and fiscal year-to-date increases are due to favorable currency exchange rates,
partially offset by lower sales volumes and price competition for products
domestically manufactured in Australia and New Zealand.
Second quarter 2004 sales for the Food Ingredients -- North America
business were comparable to sales for the same quarter last year. First half
fiscal 2004 sales increased $0.4 million, or 2%, over last year, due primarily
to an improvement in sales of potato coating products for the quick service
restaurant business.
Income from operations
Income from operations at the Company's Industrial Ingredients -- North
America business unit declined from $2.4 million in the second quarter of fiscal
2003 to $1.6 million in the second quarter of fiscal 2004 because of a decline
in gross margin and the costs related to a workforce reduction. The quarterly
gross margin declined to 13.1% from 15.6% last year primarily due to a 40%
increase in the cost of natural gas over the year ago quarter which offset the
favorable effects of pricing and increased sales volumes. In December 2003,
Penford recorded $0.5 million in pre-tax expense related to a workforce
reduction in this business segment. Restructuring costs are shown separately in
the Consolidated Statements of Income. See Note 5 to the Consolidated Financial
Statements. Income from operations decreased $2.1 million for the six months
ended February 29, 2004 compared to the same period last year due to the rise in
natural gas costs, a first half sales volume decrease of 3% and the
aforementioned restructuring costs. Gross margin decreased in the first half of
fiscal 2004 to 13.6% from 16.2% in the same period last year primarily due to a
33% increase in natural gas costs.
Income from operations at Penford's Australia/New Zealand operations
increased $0.5 to $1.5 million in the second quarter of fiscal 2004 compared to
the year ago quarter. Gross profit increased $0.7 million due to the favorable
effects of Australian and New Zealand exchange rates and the moderation of grain
costs toward the end of the quarter as high cost drought-related grain was
depleted from inventory, offset by a $0.2 million increase in operating
expenses. Gross margin as a percent of sales increased to 12.8% in the second
quarter of 2004 from 11.8% in the same period last year. Operating income for
the first six months of fiscal 2004 declined $0.7 million from the prior year on
lower sales volumes, price competition, higher grain costs and $0.3 million of
severance costs related to a reduction in the workforce. See Note 5 to the
Consolidated Financial Statements.
Second quarter income from operations at the Food Ingredients -- North
American business unit decreased $1.0 million to $0.7 million compared to the
same period in fiscal 2003, primarily due to a decrease in the unit's gross
margin. Quarterly gross margin as a percent of sales declined to 21.9% from
29.5% last year due to lower plant utilization caused by a five-week shut down
in dextrose production to balance inventories, manufacturing plant
13
inefficiencies and higher energy costs. Decreases in gross margin and income
from operations during the first half of fiscal 2004 compared to the same period
last year are attributable to the second quarter margin decline.
Corporate operating expenses
Corporate operating expenses declined $0.2 million and $0.7 million in
the three and six month periods of fiscal 2004, respectively, compared to the
same periods in the prior year. Primary contributors to the decline in both
periods are a decrease in executive personnel costs and recruiting costs and a
reduction in overall discretionary spending.
Interest and taxes
Interest expense decreased 16% and 23% in the three and six months
ended February 29, 2004, respectively, compared to the same periods in fiscal
2003 primarily due to lower average debt outstanding during the periods.
The Company's effective tax rate for the three and six months ended
February 29, 2004 and February 28, 2003 varied from the U.S. federal statutory
rate due to U. S. tax credits related to research and development and the
favorable tax effect of export sales from the U.S. Income tax expense in the
second quarter of fiscal 2004 included a $0.3 million charge for the effects of
the final implementation of the new Australian consolidation tax legislation.
Non-operating income, net
Non-operating income, net consists of the following:
Three months ended Six months ended
------------------ ------------------
February February February February
29, 2004 28, 2003 29, 2004 28, 2003
-------- -------- -------- --------
(In thousands)
Loss on early extinguishment of debt $ - $ - $ (665) $ -
Gain on sale of Hi-maize(R) business - - - 1,916
Gain on sale of investment - - 150 -
Royalty and licensing income 396 406 763 406
Other 134 (137) 257 (141)
-------- -------- -------- --------
Total $ 530 $ 269 $ 505 $ 2,181
======== ======== ======== ========
In October 2003, Penford refinanced its existing secured credit and
inventory financing credit agreements and wrote off the unamortized deferred
transaction costs related to these credit agreements. In the first quarter of
fiscal 2003, Penford sold certain assets of its resistant starch Hi-maize(R)
business and recorded a gain on the sale. The Company also licensed the rights
to its resistant starch intellectual property portfolio for applications in
human nutrition. The Company will receive annual royalties for a period of seven
years or until a maximum of $11.0 million has been received. The initial
licensing fee of $2.25 million is being amortized over the life of the royalty
agreement.
LIQUIDITY AND CAPITAL RESOURCES
At February 29, 2004, Penford had working capital of $45.5 million
compared to $39.0 million at August 31, 2003. Cash flow from operations was $8.8
million and $13.0 million for the six months ended February 29, 2004 and
February 28, 2003, respectively. The decrease in operating cash flow is
primarily due to an increase in working capital.
Cash flow from investing activities declined approximately $5.1 million
in the first half of fiscal 2004 compared to the prior year period. This decline
is due to cash receipts totaling $3.7 million related to the Company's sale of
certain assets of its Hi-maize(R) business and an upfront licensing fee for the
use of certain intellectual property in the first half of fiscal 2003 and an
increase in capital expenditures of $1.5 million.
14
On October 7, 2003, Penford replaced its existing secured credit and
inventory financing credit facilities with a new $105 million secured credit
facility with a group of U.S. and Australian banks. The revolving lines of
credit expire on October 7, 2006 and the term loans expire on October 7, 2008.
Interest rates under the new credit facility are based on either LIBOR (or the
Australian equivalent) or the prime rate, depending on the selection of
borrowing options. All of Penford's assets secure the credit facility and the
new agreement includes, among other things, financial covenants with limitations
on indebtedness and capital expenditures and maintenance of fixed charge and
leverage ratios. For the quarter ended February 29, 2004, the Company was in
compliance with the covenants and expects to be in compliance for the remainder
of the fiscal year. At February 29, 2004, the Company had $32.0 million
outstanding under its revolving credit facilities and $50.4 million in term
loans.
During the six month period ended February 29, 2004, the Company paid
dividends of $1.0 million representing $0.12 per share, the same per share
dividend rate as the six month period ended February 28, 2003. Any future
dividends will be paid at the discretion of the Company's board of directors and
will depend upon, among other things, earnings, financial condition, cash
requirements and availability, and contractual requirements.
ACCOUNTING PRINCIPLES NOT YET ADOPTED
In December 2003, the Financial Accounting Standards Board ("FASB")
issued revised SFAS No. 132 (revised 2003), "Employer's Disclosure about
Pensions and Other Post-Retirement Benefits." SFAS No. 132 (R) requires
additional disclosures in annual financial statements about the types of plan
assets, investment strategy, measurement dates, plan obligations, cash flows,
and components of net periodic benefit cost of defined benefit pension plans and
other post-retirement benefit plans. The annual disclosure requirements are
effective for fiscal years ending after December 15, 2003. SFAS No. 132 (R) also
requires interim disclosure of the elements of net periodic benefit cost and the
total amount of contributions paid or expected to be paid during the current
fiscal year if significantly different from amounts previously disclosed. The
interim disclosure requirements are effective for interim periods beginning
after December 15, 2003. The Company will adopt the disclosure requirements of
SFAS No. 132 (R) effective with the quarter beginning March 1, 2004.
In January 2004, the FASB issued FASB Staff Position No. 106-1 ("FSP
106-1"), "Accounting and Disclosure Requirements Related to the Medicare
Prescription Drug, Improvement and Modernization Act of 2003" (the "Act"). The
Act introduces a prescription drug benefit under Medicare (Medicare Part D) as
well as a federal subsidy to sponsors of post-retirement health care benefit
plans that provide a benefit that is at least actuarially equivalent to Medicare
Part D. The Company's post-retirement health care benefit plan provides no
prescription drug benefit to Medicare eligible salaried retirees, and the
prescription drug benefit provided to Medicare eligible hourly retirees is
insured and the insurance premium is fully paid by the retirees. The benefits of
the Act are expected to be realized by the Company's retirees and the Act will
have no effect on the Company's results of operations, financial position or
liquidity.
ITEM 3: QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.
The Company is exposed to market risks from adverse changes in interest
rates, foreign currency exchange rates and commodity prices. Since August 31,
2003, there have been no significant changes in the Company's exposure to market
risks.
ITEM 4: CONTROLS AND PROCEDURES.
Under the supervision and with the participation of management,
including the Chief Executive Officer and Chief Financial Officer, the Company
has evaluated the effectiveness of the design and operation of its disclosure
controls and procedures pursuant to Exchange Act Rule 13a-14(c) as of the end of
the period covered by this report. Based on that evaluation, the Chief Executive
Officer and Chief Financial Officer have concluded that these disclosure
controls and procedures are effective such that information related to the
Company required to be disclosed in the Securities and Exchange Commission
("SEC") reports (i) is recorded, processed, summarized and reported within the
time periods specified in SEC rules and forms, and (ii) is accumulated and
communicated to the Company's management, including the Chief Executive Officer
and Chief Financial Officer, as appropriate to allow timely decisions regarding
required disclosure.
15
PART II - OTHER INFORMATION
ITEM 4: SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS
The Company held its Annual Meeting of Shareholders on January 20,
2004. The only item voted upon at the meeting was the election of directors. The
results of the election are shown below. Directors not elected at this meeting
and whose term of office continued after the meeting are Richard T. Crowder,
Paul H. Hatfield, John C. Hunter III and James E. Warjone.
Percent of Percent of
Director Votes For Total Shares Votes Withheld Total Shares
- -------------------- --------- ------------ -------------- ------------
Jeffrey T. Cook 6,521,111 75.0% 42,777 0.5%
Thomas D. Malkoski 6,386,142 73.4% 177,746 2.0%
Sally G. Narodick 6,230,712 71.6% 333,176 3.8%
William E. Buchholz 6,380,335 73.3% 183,553 2.1%
R. Randolph Devening 6,530,139 75.1% 33,749 0.4%
ITEM 6: EXHIBITS AND REPORTS ON FORM 8-K.
(a) Exhibits
31.1 Certifications of Chief Executive Officer pursuant to Section
302 of the Sarbanes-Oxley Act of 2002
31.2 Certifications of Chief Financial Officer pursuant to Section
302 of the Sarbanes-Oxley Act of 2002
32 Certifications of Chief Executive Officer and Chief Financial
Officer pursuant to Section 906 of the Sarbanes-Oxley Act of
2002
(b) Reports on Forms 8-K.
A Form 8-K was filed on December 19, 2003 relating to the Registrant's
financial information for the first fiscal quarter ended November 30,
2003, as presented in a press release on December 18, 2003.
16
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
Penford Corporation
---------------------------------
(Registrant)
April 13, 2004 /s/ Steven O. Cordier
---------------------------------
Steven O. Cordier
Vice President, Chief Financial Officer
and Corporate Secretary
17
EXHIBIT INDEX
Exhibit No. Description
- ----------- ---------------------------------------------------------------------------------------------------
31.1 Certifications of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2 Certifications of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32 Certifications of Chief Executive Officer and Chief Financial Officer pursuant to Section 906 of
the Sarbanes-Oxley act of 2002
18